These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34464185)

  • 1. Reducing Opioid Overdose Deaths by Expanding Naloxone Distribution and Addressing Structural Barriers to Care.
    Smart R; Davis CS
    Am J Public Health; 2021 Aug; 111(8):1382-1384. PubMed ID: 34464185
    [No Abstract]   [Full Text] [Related]  

  • 2. Protecting Against Opioid Overdose: Naloxone Co-Prescribing.
    Nathan N
    Anesth Analg; 2022 Jul; 135(1):20. PubMed ID: 35709440
    [No Abstract]   [Full Text] [Related]  

  • 3. Naloxone in Correctional Facilities for the Prevention of Opioid Overdose Deaths.
    J Correct Health Care; 2022 Feb; 28(1):66-67. PubMed ID: 34967694
    [No Abstract]   [Full Text] [Related]  

  • 4. The innovative role of an "opioid overdose prevention pharmacist" at a mental health teaching hospital.
    Costa T; Zhang M
    Am J Health Syst Pharm; 2021 Feb; 78(4):292-296. PubMed ID: 33471052
    [No Abstract]   [Full Text] [Related]  

  • 5. Opioid overdose knowledge among college students compared to experienced opioid users.
    Jones JD; Avila JR; Smith MK; Martinez S
    Drug Alcohol Rev; 2024 Jan; 43(1):343-346. PubMed ID: 37920901
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution of naloxone for overdose prevention to chronic pain patients.
    Coe MA; Walsh SL
    Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
    Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
    Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate use disorders and overdose: Medical students' experiences, satisfaction with learning, and attitudes toward community naloxone provision.
    Tobin H; Klimas J; Barry T; Egan M; Bury G
    Addict Behav; 2018 Nov; 86():61-65. PubMed ID: 29198489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a comprehensive naloxone education program's impact on community member knowledge and attitudes on a college campus.
    Doughty B; Young S; Eggleston W
    J Am Coll Health; 2022 Jul; 70(5):1332-1335. PubMed ID: 32877623
    [No Abstract]   [Full Text] [Related]  

  • 10. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
    Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
    Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Naloxone Prescribing by Patient Age, Ethnicity, and Clinic Location Among Patients at High-Risk of Opioid Overdose.
    Kispert D; Carwile JL; Silvia KB; Eisenhardt EB; Thakarar K
    J Gen Intern Med; 2020 May; 35(5):1603-1605. PubMed ID: 31625039
    [No Abstract]   [Full Text] [Related]  

  • 12. Attitude changes following short-form opioid overdose video education: a pilot study.
    Galiher MV; Huffman M
    Harm Reduct J; 2022 Oct; 19(1):114. PubMed ID: 36241995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to and recommendations for take-home naloxone distribution: perspectives from opioid treatment programs in New Mexico.
    Salvador JG; Sussman AL; Takeda MY; Katzman WG; Moya Balasch M; Katzman JG
    Harm Reduct J; 2020 May; 17(1):31. PubMed ID: 32404109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a multidisciplinary inpatient opioid overdose education and naloxone distribution program at a large academic medical center.
    Nguyen TT; Applewhite D; Cheung F; Jacob S; Mitchell E
    Am J Health Syst Pharm; 2022 Dec; 79(24):2253-2260. PubMed ID: 36075057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid Overdose Harm Prevention: The Role of the Nurse in Patient Education.
    Gilles S
    Nurs Clin North Am; 2022 Sep; 57(3):477-488. PubMed ID: 35985734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in opioid overdose survival and naloxone administration in Pennsylvania.
    Holmes LM; Rishworth A; King BH
    Drug Alcohol Depend; 2022 Sep; 238():109555. PubMed ID: 35810621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing a public access naloxone program for public transportation stations.
    Kohli S; Garg J; Velasquez DE; Weiner SG
    Healthc (Amst); 2023 Jun; 11(2):100694. PubMed ID: 37247465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to naloxone in underserved communities.
    Pérez-Figueroa RE; Oser CB; Malinowska K
    BMJ; 2023 Apr; 381():894. PubMed ID: 37185348
    [No Abstract]   [Full Text] [Related]  

  • 19. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose.
    Dora-Laskey A; Kellenberg J; Dahlem CH; English E; Gonzalez Walker M; Brummett CM; Kocher KE
    Acad Emerg Med; 2022 Apr; 29(4):442-455. PubMed ID: 34962682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.
    Zang X; Macmadu A; Krieger MS; Behrends CN; Green TC; Morgan JR; Murphy SM; Nolen S; Walley AY; Schackman BR; Marshall BD
    Int J Drug Policy; 2021 Dec; 98():103435. PubMed ID: 34482264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.